UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter study

Molecular psychiatry, 2010-02, Vol.15 (2), p.138-145

2010

Volltextzugriff (PDF)

Amyloid β peptides in plasma in early diagnosis of Alzheimer's disease: A multicenter study with multiplexing

Experimental neurology, 2010-06, Vol.223 (2), p.366-370

2010

Volltextzugriff (PDF)

Highly conserved and disease‐specific patterns of carboxyterminally truncated Aβ peptides 1–37/38/39 in addition to 1–40/42 in Alzheimer's disease and in patients with chronic neuroinflammation

Journal of neurochemistry, 2002-05, Vol.81 (3), p.481-496

2002

Volltextzugriff (PDF)

Validation of amyloid-β peptides in CSF diagnosis of neurodegenerative dementias

Molecular psychiatry, 2007-07, Vol.12 (7), p.671-680

2007

Volltextzugriff (PDF)

Tauopathies and synucleinopathies: do cerebrospinal fluid beta-amyloid peptides reflect disease-specific pathogenesis?

Journal of Neural Transmission, 2007-07, Vol.114 (7), p.919-927

2007

Volltextzugriff (PDF)

Reduced CSF carboxyterminally truncated Aβ peptides in frontotemporal lobe degenerations

Journal of Neural Transmission, 2007-05, Vol.114 (5), p.621-628

2007

Volltextzugriff (PDF)

CSF diagnosis of Alzheimer's disease and dementia with Lewy bodies

Journal of Neural Transmission, 2006-11, Vol.113 (11), p.1771-1778

2006

Volltextzugriff (PDF)

Follow-up investigations in cerebrospinal fluid of patients with dementia with Lewy bodies and Alzheimer's disease

Journal of Neural Transmission, 2005-06, Vol.112 (7), p.933-948

2005

Volltextzugriff (PDF)

Aminoterminally truncated and oxidized amyloid-beta peptide species in Alzheimer’s disease

Neuroscience, 2007-04, Vol.146 (1), p.17-18

2007

Volltextzugriff (PDF)

New perspectives in the laboratory diagnosis of dementia

Nervenarzt, 2008-11, Vol.79 Suppl 3, p.139-46; quiz 147-8

2008

Volltextzugriff (PDF)

Neue Perspektiven in der laborchemischen Diagnostik bei Demenzen

Nervenarzt, 2008-12, Vol.79 (Suppl 3), p.139-148

2008

Volltextzugriff (PDF)

Selective reduction of amyloid beta 42 discriminates Alzheimer's disease from Huntington's disease: indication for distinct pathological events in amyloid beta peptide aggregation

Journal of neurology, neurosurgery and psychiatry, 2006-10, Vol.77 (10), p.1201-1203

2006

Volltextzugriff (PDF)

Selective reduction of amyloid β42 discriminates Alzheimer’s disease from Huntington’s disease: indication for distinct pathological events in amyloid β peptide aggregation

Journal of neurology, neurosurgery and psychiatry, 2006-10, Vol.77 (10), p.1201-1203

2006

Volltextzugriff (PDF)

CSF amyloid-β-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia

Brain (London, England : 1878), 2006-05, Vol.129 (5), p.1177-1187

2006

Volltextzugriff (PDF)

Stability of amyloid-β peptides in plasma and serum

Electrophoresis, 2012-02, Vol.33 (3), p.445-450

2012

Volltextzugriff (PDF)

Neurochemische Demenzdiagnostik – Quo vadis?

Nervenheilkunde, 2007, Vol.26 (10), p.861-866

2007

Volltextzugriff (PDF)

Neurochemische Frühdiagnostik und klinische Neuroproteomik demenzieller Erkrankungen

Nervenheilkunde, 2007, Vol.26 (10), p.853-860

2007

Volltextzugriff (PDF)

Effect of sample collection tubes on cerebrospinal fluid concentrations of tau proteins and amyloid beta peptides

Clinical chemistry (Baltimore, Md.), 2006-02, Vol.52 (2), p.332-334

2006

Volltextzugriff (PDF)

Urine-kinetics of Low Molecular Polyethylene Glycols Following an Oral Capsule Ingestion

Journal of Applied Life Sciences International, 2018-01, Vol.15 (4), p.1-6

2018

Volltextzugriff (PDF)

Cerebrospinal fluid amyloid β peptide patterns in Alzheimer's disease patients and nondemented controls depend on sample pretreatment: Indication of carrier-mediated epitope masking of amyloid β peptides

Electrophoresis, 2004-09, Vol.25 (17), p.2912-2918

2004

Volltextzugriff (PDF)

Amyloid β peptides in cerebrospinal fluid as profiled with surface enhanced laser desorption/ionization time-of-flight mass spectrometry: evidence of novel biomarkers in Alzheimer's disease

Biological psychiatry (1969), 2004-03, Vol.55 (5), p.524-530

2004

Volltextzugriff (PDF)

Heart fatty acid binding protein as a potential diagnostic marker for neurodegenerative diseases

Neuroscience letters, 2004-11, Vol.370 (1), p.36-39

2004

Volltextzugriff (PDF)

Characterization of cerebrospinal fluid aminoterminally truncated and oxidized amyloid-β peptides

Proteomics. Clinical applications, 2012-04, Vol.6 (3-4), p.163-169

2012

Volltextzugriff (PDF)

Biomarker bei neurodegenerativen Demenzen

Aktuelle Neurologie, 2008-12, Vol.35 (10), p.526-538

2008

Volltextzugriff (PDF)

Tau protein phosphorylated at threonine 181 in CSF as a neurochemical biomarker in Alzheimer's disease: original data and review of the literature

Journal of molecular neuroscience, 2004-01, Vol.23 (1-2), p.115-122

2004

Volltextzugriff (PDF)

1 – 25 von 71

Suche als RSS-Feed

Aktive Filter

SpracheFranzösisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(66)
Mit Volltextzugriff
(57)

Publikationsform

Sprache

Englisch
(61)
Deutsch
(11)

Erscheinungsjahr

n.n

Thema

Science & Technology
(45)
Life Sciences & Biomedicine
(39)
Humans
(32)
Aged
(25)
Male
(25)
Female
(24)
Middle Aged
(22)
Neurosciences & Neurology
(22)
Amyloid Beta-Peptides - Cerebrospinal Fluid
(19)
Cerebrospinal Fluid
(19)
Alzheimer's Disease
(17)
Neurology
(17)
Aged, 80 And Over
(16)
Alzheimer Disease - Cerebrospinal Fluid
(16)
Biological And Medical Sciences
(15)
Medical Sciences
(15)
Neurosciences
(15)
Alzheimer Disease - Diagnosis
(14)
Clinical Neurology
(14)
Biomarkers - Cerebrospinal Fluid
(13)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter study

Amyloid β peptides in plasma in early diagnosis of Alzheimer's disease: A multicenter study with multiplexing

Highly conserved and disease‐specific patterns of carboxyterminally truncated Aβ peptides 1–37/38/39 in addition to 1–40/42 in Alzheimer's disease and in patients with chronic neuroinflammation

Validation of amyloid-β peptides in CSF diagnosis of neurodegenerative dementias

Tauopathies and synucleinopathies: do cerebrospinal fluid beta-amyloid peptides reflect disease-specific pathogenesis?

Reduced CSF carboxyterminally truncated Aβ peptides in frontotemporal lobe degenerations

CSF diagnosis of Alzheimer's disease and dementia with Lewy bodies

Follow-up investigations in cerebrospinal fluid of patients with dementia with Lewy bodies and Alzheimer's disease

Aminoterminally truncated and oxidized amyloid-beta peptide species in Alzheimer’s disease

New perspectives in the laboratory diagnosis of dementia

Neue Perspektiven in der laborchemischen Diagnostik bei Demenzen

Selective reduction of amyloid beta 42 discriminates Alzheimer's disease from Huntington's disease: indication for distinct pathological events in amyloid beta peptide aggregation

Selective reduction of amyloid β42 discriminates Alzheimer’s disease from Huntington’s disease: indication for distinct pathological events in amyloid β peptide aggregation

CSF amyloid-β-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia

Stability of amyloid-β peptides in plasma and serum

Neurochemische Demenzdiagnostik – Quo vadis?

Neurochemische Frühdiagnostik und klinische Neuroproteomik demenzieller Erkrankungen

Effect of sample collection tubes on cerebrospinal fluid concentrations of tau proteins and amyloid beta peptides

Urine-kinetics of Low Molecular Polyethylene Glycols Following an Oral Capsule Ingestion

Cerebrospinal fluid amyloid β peptide patterns in Alzheimer's disease patients and nondemented controls depend on sample pretreatment: Indication of carrier-mediated epitope masking of amyloid β peptides

Amyloid β peptides in cerebrospinal fluid as profiled with surface enhanced laser desorption/ionization time-of-flight mass spectrometry: evidence of novel biomarkers in Alzheimer's disease

Heart fatty acid binding protein as a potential diagnostic marker for neurodegenerative diseases

Characterization of cerebrospinal fluid aminoterminally truncated and oxidized amyloid-β peptides

Biomarker bei neurodegenerativen Demenzen

Tau protein phosphorylated at threonine 181 in CSF as a neurochemical biomarker in Alzheimer's disease: original data and review of the literature

Aktive Filter

Suchergebnisse filtern